Genprex
GNPX
20 hedge funds and large institutions have $6.1M invested in Genprex in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
154% more call options, than puts
Call options by funds: $705K | Put options by funds: $278K
0% more funds holding
Funds holding: 20 → 20 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
43% less capital invested
Capital invested by funds: $10.8M → $6.1M (-$4.66M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$70.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.4K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$70.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$70.4K |
| 5 |
VF
Virtu Financial
New York
|
+$70.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$279K |
| 2 |
Goldman Sachs
New York
|
-$211K |
| 3 |
Millennium Management
New York
|
-$141K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$70.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$70.4K |
GNPX Hedge Fund Activity: Q2 2022 in Review
20 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2022, worth a combined $6.1M — down 43% from $10.8M a quarter earlier.
Fund positioning in GNPX was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $70.4K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $279K sold.
- 20 institutional investors held Genprex (GNPX) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $6.1M of Genprex stock for Q2 2022, down 43% quarter-over-quarter.
- 4 funds opened new Genprex positions in Q2 2022 and 4 closed out, a net change of 0 holders.
- The largest Genprex buyer in Q2 2022 was Dimensional Fund Advisors, an estimated $70.4K added.
- The largest Genprex seller in Q2 2022 was GSA Capital Partners, an estimated $279K sold.
Based on aggregated 13F filings for Q2 2022.